Corvus Pharmaceuticals, Inc. Investment Income, Interest
Corvus Pharmaceuticals, Inc. (CRVS) reported Investment Income, Interest of $343.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-03.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2018-05-03
- Corvus Pharmaceuticals, Inc. investment income, interest for the quarter ending 2018-03-31 was $343.00K, a 89.50% increase year-over-year.
- Corvus Pharmaceuticals, Inc. investment income, interest for the quarter ending 2017-09-30 was $227.00K, a 26.82% increase year-over-year.
- Corvus Pharmaceuticals, Inc. investment income, interest for the quarter ending 2017-06-30 was $193.00K, a 7.22% increase year-over-year.
- Corvus Pharmaceuticals, Inc. investment income, interest for the quarter ending 2017-03-31 was $181.00K, a 129.11% increase year-over-year.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month |
|---|---|---|---|
| 2018-03-31 | $343.00K 10-Q · filed 2018-05-03 | ||
| 2017-09-30 | $227.00K 10-Q · filed 2017-11-02 | $420.00K derived: sum of 2 quarters · filed 2017-11-02 | $601.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $193.00K 10-Q · filed 2017-08-03 | $374.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $181.00K 10-Q · filed 2018-05-03 | ||
| 2016-09-30 | $179.00K 10-Q · filed 2017-11-02 | $359.00K derived: sum of 2 quarters · filed 2017-11-02 | $437.00K 10-Q · filed 2017-11-02 |
| 2016-06-30 | $180.00K 10-Q · filed 2017-08-03 | $259.00K 10-Q · filed 2017-08-03 | |
| 2016-03-31 | $79.00K 10-Q · filed 2017-05-04 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.00K 10-Q · filed 2016-08-04 | |
| 2015-03-31 | $1.00K 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |